VDB-75158 · CVE-2015-3459 · BID 74414

Hospira Lifecare PCA Infusion Pump 412 Telnet Service access control

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.

A vulnerability was found in Hospira Lifecare PCA Infusion Pump 412 (Medical Device Software). It has been rated as very critical. Affected by this issue is some unknown processing of the component Telnet Service. The manipulation with an unknown input leads to a privilege escalation vulnerability. Using CWE to declare the problem leads to CWE-264. Impacted is confidentiality, integrity, and availability. CVE summarizes:

Hospira Lifecare PCA infusion pump running "SW ver 412" does not require authentication for Telnet sessions, which allows remote attackers to gain root privileges via TCP port 23.

The weakness was presented 04/29/2015 (Website). The advisory is available at twitter.com. This vulnerability is handled as CVE-2015-3459 since 04/29/2015. The exploitation is known to be easy. The attack may be launched remotely. No form of authentication is required for exploitation. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 03/30/2019). This vulnerability is assigned to T1068 by the MITRE ATT&CK project.

Addressing this vulnerability is possible by firewalling tcp/23 (telnet).





CPE 2.3info

CPE 2.2info


VulDB Meta Base Score: 9.8
VulDB Meta Temp Score: 9.6

VulDB Base Score: 9.8
VulDB Temp Score: 9.6
VulDB Vector: 🔍
VulDB Reliability: 🔍



VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

NVD Base Score: 🔍


Class: Privilege escalation
CWE: CWE-264
ATT&CK: T1068

Local: No
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍


Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍


Recommended: Firewall
Status: 🔍

0-Day Time: 🔍

Firewalling: 🔍


04/27/2015 🔍
04/29/2015 +2 days 🔍
04/29/2015 +0 days 🔍
04/29/2015 +0 days 🔍
04/30/2015 +1 days 🔍
03/30/2019 +1430 days 🔍


Advisory: twitter.com
Status: Not defined

CVE: CVE-2015-3459 (🔍)
SecurityFocus: 74414 - Hospira Lifecare PCA Infusion Pump CVE-2015-3459 Authentication Bypass Vulnerability


Created: 04/30/2015 09:50 AM
Updated: 03/30/2019 10:04 AM
Changes: (3) source_securityfocus source_securityfocus_date source_securityfocus_class
Complete: 🔍


No comments yet. Languages: en.

Please log in to comment.

Want to stay up to date on a daily basis?

Enable the mail alert feature now!